Skip to main content
. Author manuscript; available in PMC: 2020 May 28.
Published in final edited form as: World Neurosurg. 2015 Dec 31;88:260–269. doi: 10.1016/j.wneu.2015.12.081

Table 1:

Baseline Characteristics

Total % White % Black % Hispanic % Asian/Indian % p-Value
Age at Diagnosis (N) 428 313 73.1 21 4.9 77 18.0 17 4.0 0.379
<50 102 23.8 74 23.6 7 33.3 15 19.5 6 35.3
≥50 326 76.2 239 76.4 14 66.7 62 80.5 11 64.7
Gender (N) 428 313 73.1 21 4.9 77 18.0 17 4.0 0.911
Male 247 57.7 181 57.8 11 52.4 46 59.7 9 52.9
Female 181 42.3 132 42.2 10 47.6 31 40.3 8 47.1
Marital Status (N) 425 311 73.2 21 4.9 76 17.9 17 4.0 0.001
Married 299 70.4 235 75.6 9 42.9 40 52.6 15 88.2
Unmarried 126 29.6 76 24.4 12 57.1 36 47.4 2 11.8
KPS (N) 428 313 73.1 21 4.9 77 18.0 17 4.0 0.459
≥70 346 80.8 258 82.4 16 76.2 58 75.3 14 82.4
<70 82 19.2 55 17.6 5 23.8 19 24.7 3 17.6
Extent of Surgical Resection (N) 302 217 71.9 16 5.3 57 18.9 12 4.0 0.411
Gross Total Resection 193 63.9 139 64.1 13 81.3 32 56.1 9 75.0
Subtotal Resection 45 14.9 29 13.4 2 12.5 13 22.8 1 8.9
Biopsy 64 21.2 49 22.6 1 6.3 12 21.1 2 16.7
RPA Class (N) 366 264 72.1 18 4.9 68 18.6 16 4.4 0.203
III 38 10.4 30 11.4 1 5.6 5 7.4 2 12.5
IV 224 61.2 163 44.5 15 4.1 36 52.9 10 62.5
V/VI 104 28.4 71 26.9 2 11.1 27 39.7 4 25.0
RT Technique (N) 421 308 73.2 20 4.8 76 18.1 17 4.0 0.001
IMRT 231 54.9 169 54.9 12 60.0 38 50.0 12 70.6
3D CRT 170 40.4 133 43.2 7 35.0 26 34.2 4 23.5
2D 20 4.8 6 1.9 1 5.0 12 15.8 1 5.9
RT Total Dose (N) 428 313 73.1 21 4.9 77 18.0 17 4.0 0.617
<36 Gy 42 9.8 32 10.2 2 9.5 8 10.4 0 0
36–54 Gy 41 9.6 31 9.9 0 0 9 11.7 1 5.9
>54 Gy 345 80.6 250 29.9 19 90.5 60 77.9 16 94.1
Laterality (N) 399 290 72.7 20 5.0 73 18.3 16 4.0 0.973
Unilateral 331 83.0 241 83.1 17 85.0 60 82.2 13 81.3
Bilateral 68 17.0 49 16.9 3 15.0 13 17.8 3 18.8
Multicentricity (N) 399 290 72.7 20 5.0 73 18.3 16 4.0 0.278
No 314 78.7 222 76.6 17 85.0 63 86.3 12 75.0
Yes 85 21.3 68 23.4 3 15.0 10 13.7 4 25.0
IDH-1 Status (N) 93 68 73.1 3 3.2 16 17.2 6 6.5 0.406
Negative 87 93.5 63 92.6 3 100 16 100 5 83.3
Positive 6 6.5 5 7.4 0 0 0 0 1 16.7
MGMT Status (N) 65 46 70.8 2 3.1 12 18.5 5 7.7 0.259
Unmethylated 38 58.5 28 60.9 2 100 7 58.3 1 20.0
Methylated 27 41.5 18 29.1 0 0 5 41.7 4 80.0
Temozolomide (N) 286 208 72.7 15 5.2 51 17.8 12 4.2 0.216
Yes 265 92.7 191 91.8 13 86.7 50 98.0 11 91.7
No 21 7.3 17 18.2 2 13.3 1 2.0 1 8.3